(Q48267690)

10 February 2018

title

Serotonin transporter gene: a new polymorphism may affect response to antidepressant treatments in major depressive disorder. (English)

1 reference

10 February 2018

0 references

4

1 reference

10 February 2018

Pierluigi Politi

5

1 reference

10 February 2018

Matteo Balestrieri

16

1 reference

10 February 2018

Alessandro Serretti

object named as

Alessandro Serretti

17

0 references

Paolo Brambilla

15

object named as

Paolo Brambilla

1 reference

10 February 2018

author name string

Yoshihiko Matsumoto

1

1 reference

10 February 2018

Chiara Fabbri

2

1 reference

10 February 2018

Silvia Pellegrini

3

1 reference

10 February 2018

Silvio Bellino

6

1 reference

10 February 2018

Caterina Iofrida

7

1 reference

10 February 2018

Veronica Mariotti

8

1 reference

10 February 2018

Erika Melissari

9

1 reference

10 February 2018

Marco Menchetti

10

1 reference

10 February 2018

Valentina Martinelli

11

1 reference

10 February 2018

Marco Cappucciati

12

1 reference

10 February 2018

Paola Bozzatello

13

1 reference

10 February 2018

Elena Brignolo

14

1 reference

10 February 2018

publication date

1 October 2014

1 reference

10 February 2018

Molecular Diagnosis and Therapy

published in

1 reference

10 February 2018

volume

18

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

page(s)

567-577

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s40291-014-0110-7

exact match

0 references

cites work

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Strategies to improve the management of depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Pharmacogenetics of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Pharmacogenetics of antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Serotonin-induced platelet intracellular Ca2+ responses in untreated depressed patients and imipramine responders in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

A naturally occurring amino acid substitution of the human serotonin 5-HT2A receptor influences amplitude and timing of intracellular calcium mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Investigation of serotonin-related genes in antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Serotonin transporter gene, depressive symptoms, and interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Lack of association of TPH2 exon XI polymorphisms with major depression and treatment resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Genetic architecture of the human tryptophan hydroxylase 2 Gene: existence of neural isoforms and relevance for major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Tryptophan hydroxylase 2 gene is associated with major depressive disorder in a female Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

TPH2 gene polymorphisms and major depression--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Pharmacogenetics in major depression: a comprehensive meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Transcriptional regulation by the phosphorylation-dependent factor CREB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Function and regulation of CREB family transcription factors in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Genome survey for susceptibility loci for recurrent, early-onset major depression: results at 10cM resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

D2S2944 identifies a likely susceptibility locus for recurrent, early-onset, major depression in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

CREB1 is a strong genetic predictor of the variation in exercise heart rate response to regular exercise: the HERITAGE Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

No effect of serotoninergic gene variants on response to interpersonal counseling and antidepressants in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

The outcomes of interpersonal counselling on depressive symptoms and distress after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Depression in primary care: interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter randomized controlled trial. Rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Accurate, Large-Scale Genotyping of 5HTTLPR and Flanking Single Nucleotide Polymorphisms in an Association Study of Depression, Anxiety, and Personality Measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Association study of a brain‐derived neurotrophic‐factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

DRD3, but not BDNF, genotype affects treatment response to paroxetine in major depressive disorder: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and the early response to antidepressant in Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

The role of personality pathology in depression treatment outcome with psychotherapy and pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

A comparative study of venlafaxine with a focused education and psychotherapy program versus venlafaxine alone in the treatment of depression in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

The tryptophan hydroxylase (TPH) 2 gene unlike TPH-1 exhibits no association with stress-induced depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0110-7

Cytokine production and treatment response in major depressive disorder

21 January 2018

1 reference

12 December 2020

Changes in CREB-phosphorylation during recovery from major depression

1 reference

12 December 2020

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

1 reference

12 December 2020

Genotyping of the G1463A (Arg441His) TPH2 polymorphism in a geriatric population of patients with major depression

1 reference

12 December 2020

Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project.

1 reference

12 December 2020

Serotonin-induced platelet intracellular calcium mobilization in depressed patients

1 reference

12 December 2020

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.

1 reference

12 December 2020

The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes

1 reference

12 December 2020

10.1007/S40291-014-0110-7

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

24958631

1 reference

10 February 2018